Cargando…

Immunotherapy in Hepatocellular Carcinoma

Patients with hepatocellular carcinoma (HCC) have been traditionally deprived from highly effective systemic therapy options in the past decades. The multi-targeted tyrosine kinase inhibitor sorafenib, approved in 2008, remained the only treatment option for advanced HCC for over a decade. A number...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulgenzi, Claudia A. M., Talbot, Thomas, Murray, Sam M., Silletta, Marianna, Vincenzi, Bruno, Cortellini, Alessio, Pinato, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Upper Gastrointestinal Cancers (JD Berlin, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382645/ https://www.ncbi.nlm.nih.gov/pubmed/34424422 http://dx.doi.org/10.1007/s11864-021-00886-5

Ejemplares similares

Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis
por: Daniell, Kayla M., et al.
Publicado: (2022)

Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
por: Malla, Midhun, et al.
Publicado: (2022)

Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors
por: Akahoshi, Kazuya, et al.
Publicado: (2020)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

Approach to Localized Squamous Cell Cancer of the Esophagus
por: Weidenbaum, Chloe, et al.
Publicado: (2022)

Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers
por: Brown, Leo R., et al.
Publicado: (2022)

Surgery Matters: Progress in Surgical Management of Gastric Cancer
por: Beyer, Katharina
Publicado: (2023)

Gastric schwannoma: a benign tumour often mistaken clinically, radiologically and histopathologically for a gastrointestinal stromal tumour – a case series
por: Williamson, JML, et al.
Publicado: (2012)

Detection of sarcopenic obesity and prediction of long‐term survival in patients with gastric cancer using preoperative computed tomography and machine learning
por: Kim, Jaehyuk, et al.
Publicado: (2021)

Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study
por: Bracale, Umberto, et al.
Publicado: (2021)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Nonsurgical Treatment for Localized Hepatocellular Carcinoma
por: Kennedy, Andrew S., et al.
Publicado: (2014)

Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
por: Chan, Jennifer, et al.
Publicado: (2014)

Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
por: Yasuda, Shigeo, et al.
Publicado: (2019)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2
por: Finn, Richard S, et al.
Publicado: (2022)

Endoscopic modalities for upper gastrointestinal leaks, fistulae and perforations
por: Talbot, Michael, et al.
Publicado: (2015)

Early Gastric Cancer Associated With Gastric Sarcoidosis
por: Matsubara, Takeshi, et al.
Publicado: (2015)

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
por: Schunke, Kathryn J., et al.
Publicado: (2017)

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
por: Azzi, Georges, et al.
Publicado: (2022)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021)

Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
por: Zeng, Zhijun, et al.
Publicado: (2020)

Berlín 1919-1933 : gigantismo, crisis social y vanguardia: la máxima encarnación de la modernidad
Publicado: (1991)

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
por: Manfredi, Giulia Francesca, et al.
Publicado: (2023)

Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
por: Jiang, Man, et al.
Publicado: (2022)

Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
por: Zhou, Xi‐Lei, et al.
Publicado: (2019)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

A case of pseudoglandular hepatocellular carcinoma: The usefulness of a multimodal approach
por: Watanabe, Hirofumi, et al.
Publicado: (2018)

Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas
por: Dasari, Arvind, et al.
Publicado: (2022)

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Zhuang, Tony Z, et al.
Publicado: (2022)

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
por: Smyth, Elizabeth C, et al.
Publicado: (2021)

Feasibility of definitive chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma: A retrospective study
por: Watanabe, Akinori, et al.
Publicado: (2018)

Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study
por: Lam, Robert, et al.
Publicado: (2022)

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)
por: Bendell, Johanna C., et al.
Publicado: (2019)

Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report
por: Wolfe, Adam R., et al.
Publicado: (2018)

A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma
por: Cedillo, Mario A., et al.
Publicado: (2019)

A case of primary clear cell hepatocellular carcinoma comprised mostly of clear cells
por: Kokubo, Reiji, et al.
Publicado: (2019)

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study
por: Mentrasti, Giulia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5q966pusuq3m00updp1jct94ui